Qiagen beats Street

Research tool supplier Qiagen (FSE:QIA; QGENF) reported second quarter EPS of $0.10, beating the Street by $0.02 and up 25% from $0.08 in the same period last year. QIA's earnings exclude extraordinary charges related to relocation and restructuring, as well as costs related to the management buyout of its synthetic DNA business unit. Net sales for the quarter came in at $98.6 million, up 14% from $86.3 million in the second quarter of 2003. For the year, QIA raised its revenue guidance to $376-$381 million from $373-$380 and raised the low end of its EPS guidance to $0.36 from $0.35 while maintaining the upper end of $0.38. ...